Cytosorbents (CTSO) Reports In-Line Q3 EPS
Cytosorbents (NASDAQ: CTSO) reported Q3 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $3.45 million versus the consensus estimate of $3.86 million.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.